logo
Share SHARE
FONT-SIZE Plus   Neg

Curis Swings To Q4 Profit

Curis, Inc. (CRIS) reported net income for the fourth quarter of $6.1 million or $0.07 per share, compared to a net loss of $5.6 million or $0.07 per share for the year-ago quarter.

Revenues for the fourth quarter surged ti $14.1 million from $100,000 a year ago. The increase is the result of $14.0 million in license fee revenues recorded during the fourth quarter of 2011 for payments that Curis received from Genentech for the achievement of certain regulatory objectives related to Erivedge.

Analysts polled by Thomson Reuters expected the company to earn $0.06 per share on revenue of $10.16 million for the fourth quarter.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
We are well into the third quarter and past the middle of the year and it is time to take stock of regulatory decisions awaiting some biotech stocks in August. Despite the uncertain macroeconomic environment, the markets have run up, with the S&P 500 Index making new highs session after session. Valuation concerns may keep traders at bay. However, the biotech space is a different cup of tea. Alphabet Inc., (GOOG, GOOGL), the parent company of Google, Thursday reported an increase in profit for the second quarter, driven mostly by increase in search and advertising revenues. Earnings and revenues for the quarter trumped Wall Street expectations, sending shares of the company up by 3 percent... Apple Inc. (AAPL) has announced that it recently sold its 1 billionth iPhone, about nine years after the first iPhone was launched. "iPhone has become one of the most important, world-changing and successful products in history. It's become more than a constant companion. iPhone is truly an essential...
comments powered by Disqus
Follow RTT